{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:25:55Z","timestamp":1771035955612,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,11,16]],"date-time":"2012-11-16T00:00:00Z","timestamp":1353024000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytotechnology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s10616-012-9513-7","type":"journal-article","created":{"date-parts":[[2012,11,15]],"date-time":"2012-11-15T11:30:00Z","timestamp":1352979000000},"page":"597-608","source":"Crossref","is-referenced-by-count":13,"title":["Enhanced suppression of proliferation and migration in highly-metastatic lung cancer cells by combination of valproic acid and coumarin-3-carboxylic acid and its molecular mechanisms of action"],"prefix":"10.1007","volume":"65","author":[{"given":"Xin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fujia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,16]]},"reference":[{"key":"9513_CR1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/med.10017","volume":"22","author":"RA Blaheta","year":"2002","unstructured":"Blaheta RA, Cinatl J Jr (2002) Anti-tumor mechanisms of valproate: a novel role for an old drug. Med Res Rev 22:492\u2013511","journal-title":"Med Res Rev"},{"key":"9513_CR2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.canlet.2009.02.045","volume":"281","author":"SS Byun","year":"2009","unstructured":"Byun SS, Kim FJ, Khandrika L, Kumar B, Koul S, Wilson S, Koul HK (2009) Differential effects of valproic acid on growth, proliferation and metastasis in HTB5 and HTB9 bladder cancer cell lines. Cancer Lett 281:196\u2013202","journal-title":"Cancer Lett"},{"key":"9513_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.canlet.2011.07.015","volume":"311","author":"YW Chou","year":"2011","unstructured":"Chou YW, Chaturvedi NK, Ouyang S, Lin FF, Kaushik D, Wang J, Kim I, Lin MF (2011) Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells. Cancer Lett 311:177\u2013186","journal-title":"Cancer Lett"},{"key":"9513_CR4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10637-009-9331-8","volume":"29","author":"J Colon","year":"2011","unstructured":"Colon J, Basha MR, Madero-Visbal R, Konduri S, Baker CH, Herrera LJ, Safe S, Sheikh-Hamad D, Abudayyeh A, Alvarado B, Abdelrahim M (2011) Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice. Invest New Drugs 29:41\u201351","journal-title":"Invest New Drugs"},{"key":"9513_CR5","doi-asserted-by":"crossref","unstructured":"Hudak L, Tezeeh P, Wedel S, Makarevi\u0107 J, Juengel E, Tsaur I, Bartsch G, Wiesner C, Haferkamp A, Blaheta RA (2012) Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion. Prostate 72(16):1719\u20131735","DOI":"10.1002\/pros.22525"},{"key":"9513_CR6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71\u201396","journal-title":"CA Cancer J Clin"},{"key":"9513_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69\u201390","journal-title":"CA Cancer J Clin"},{"key":"9513_CR8","first-page":"578","volume":"62","author":"Y Jiang","year":"2010","unstructured":"Jiang Y, Zhang Y, Luan J, Duan H, Yagasaki K, Zhang G (2010) Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action. Cytotechnology 62:578\u2013583","journal-title":"Cytotechnology"},{"key":"9513_CR9","doi-asserted-by":"crossref","first-page":"18158","DOI":"10.1074\/jbc.M800186200","volume":"283","author":"S Kim","year":"2008","unstructured":"Kim S, Lee UJ, Kim MN, Lee EJ, Kim JY, Lee MY, Choung S, Kim YJ, Choi YC (2008a) MicroRNA miR-199a regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). J Biol Chem 283:18158\u201318166","journal-title":"J Biol Chem"},{"key":"9513_CR10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.lungcan.2007.08.008","volume":"59","author":"YT Kim","year":"2008","unstructured":"Kim YT, Kim TY, Lee DS, Park SJ, Park JY, Seo SJ, Choi HS, Kang HJ, Hahn S, Kang CH, Sung SW, Kim JH (2008b) Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung. Lung Cancer 59:111\u2013118","journal-title":"Lung Cancer"},{"key":"9513_CR11","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbrc.2012.01.049","volume":"418","author":"NH Kim","year":"2012","unstructured":"Kim NH, Kim SN, Oh JS, Lee S, Kim YK (2012) Anti-mitotic potential of 7-diethylamino-3(2\u2032-benzoxazolyl)-coumarin in 5-fluorouracil-resistant human gastric cancer cell line SNU620\/5-FU. Biochem Biophys Res Commun 418:616\u2013621","journal-title":"Biochem Biophys Res Commun"},{"key":"9513_CR12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/1078-0432.CCR-11-0946","volume":"18","author":"S Landreville","year":"2012","unstructured":"Landreville S, Agapova OA, Matatall KA, Kneass ZT, Onken MD, Lee RS, Bowcock AM, Harbour JW (2012) Histone deacetylase inhibitors induce growth arrest and 16 differentiation in uveal melanoma. Clin Cancer Res 18:408\u2013416","journal-title":"Clin Cancer Res"},{"key":"9513_CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4238\/2012.January.13.1","volume":"11","author":"GF Li","year":"2012","unstructured":"Li GF, Qian TL, Li GS, Yang CX, Qin M, Huang J, Sun M, Han YQ (2012) Sodium valproate inhibits MDA-MB-231 breast cancer cell migration by upregulating NM23H1 expression. Genet Mol Res 11:77\u201386","journal-title":"Genet Mol Res"},{"key":"9513_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cbi.2009.01.011","volume":"180","author":"TH Lin","year":"2009","unstructured":"Lin TH, Lu FJ, Yin YF, Tseng TH (2009) Enhancement of esculetin on arsenic trioxide-provoked apoptosis in human leukemia U937 cells. Chem Biol Interact 180:61\u201368","journal-title":"Chem Biol Interact"},{"key":"9513_CR15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10616-009-9223-y","volume":"59","author":"Q Liu","year":"2009","unstructured":"Liu Q, Duan H, Luan J, Yagasaki K, Zhang G (2009) Effects of theanine on growth of human lung cancer and leukemia cells as well as migration and invasion of human lung cancer cells. Cytotechnology 59:211\u2013217","journal-title":"Cytotechnology"},{"key":"9513_CR16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10616-009-9250-8","volume":"62","author":"J Luan","year":"2010","unstructured":"Luan J, Duan H, Liu Q, Yagasaki K, Zhang G (2010) Inhibitory effects of norcantharidin against human lung cancer cell growth and migration. Cytotechnology 62:349\u2013355","journal-title":"Cytotechnology"},{"key":"9513_CR17","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nature01101","volume":"419","author":"VS Marsden","year":"2002","unstructured":"Marsden VS, O\u2019Connor L, O\u2019Reilly LA, Silke J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K, Tomaselli KJ, Roy S, Nicholson DW, Vaux DL, Bouillet P, Adams JM, Strasser A (2002) Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c\/Apaf-1\/caspase-9 apoptosome. Nature 419:634\u2013637","journal-title":"Nature"},{"key":"9513_CR19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/jcp.20666","volume":"208","author":"MP Morelli","year":"2006","unstructured":"Morelli MP, Cascone T, Troiani T, Tuccillo C, Bianco R, Normanno N, Romano M, Veneziani BM, Fontanini G, Eckhardt SG, De Pacido S, Tortora G, Ciardiello F (2006) Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases. Cell Physiol 208:344\u2013353","journal-title":"Cell Physiol"},{"key":"9513_CR20","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/1078-0432.CCR-08-1930","volume":"15","author":"P Munster","year":"2009","unstructured":"Munster P, Marchion D, Bicaku E, Lacevic M, Kim J, Centeno B, Daud A, Neuger A, Minton S, Sullivan D (2009) Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I\/II trial of valproic acid and epirubicin\/FEC. Clin Cancer Res 15:2488\u20132496","journal-title":"Clin Cancer Res"},{"key":"9513_CR21","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1158\/1078-0432.CCR-08-2904","volume":"15","author":"GN Naumov","year":"2009","unstructured":"Naumov GN, Nilsson MB, Cascone T, Briggs A, Straume O, Akslen LA, Lifshits E, Byers LA, Xu L, Wu HK, J\u00e4nne P, Kobayashi S, Halmos B, Tenen D, Tang XM, Engelman J, Yeap B, Folkman J, Johnson BE, Heymach JV (2009) Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance. Clin Cancer Res 15:3484\u20133494","journal-title":"Clin Cancer Res"},{"key":"9513_CR22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","volume":"74","author":"ZN Oltvai","year":"1993","unstructured":"Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609\u2013619","journal-title":"Cell"},{"key":"9513_CR23","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1464-410X.2009.08795.x","volume":"105","author":"A Ozawa","year":"2010","unstructured":"Ozawa A, Tanji N, Kikugawa T, Sasaki T, Yanagihara Y, Miura N, Yokoyama M (2010) Inhibition of bladder tumour growth by histone deacetylase inhibitor. BJU Int 105:1181\u20131186","journal-title":"BJU Int"},{"key":"9513_CR24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/1477-3163.44372","volume":"7","author":"N Puri","year":"2008","unstructured":"Puri N, Salgia R (2008) Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer. J Carcinog 7:9","journal-title":"J Carcinog"},{"key":"9513_CR25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.tiv.2010.11.015","volume":"25","author":"FB Rassouli","year":"2011","unstructured":"Rassouli FB, Matin MM, Iranshahi M, Bahrami AR, Behravan J, Mollazadeh S, Neshati V, Kalalinia F (2011) Investigating the enhancement of cisplatin cytotoxicity on 5637 cells by combination with mogoltacin. Toxicol In Vitro 25:469\u2013474","journal-title":"Toxicol In Vitro"},{"key":"9513_CR26","first-page":"S9","volume":"34","author":"JC Reed","year":"1997","unstructured":"Reed JC (1997) Bcl-2 family proteins: regulators of apoptosis and chemoresistance inhematologic malignancies. Semin Hematol 34:S9\u2013S19","journal-title":"Semin Hematol"},{"key":"9513_CR27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","volume":"61","author":"R Siegel","year":"2011","unstructured":"Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212\u2013236","journal-title":"CA Cancer J Clin"},{"key":"9513_CR28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10\u201329","journal-title":"CA Cancer J Clin"},{"key":"9513_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0167-4838(99)00281-2","volume":"1477","author":"HR Stennicke","year":"2000","unstructured":"Stennicke HR, Salvesen GS (2000) Caspases\u2014controlling intracellular signals by protease zymogen activation. Biochim Biophys Acta 1477:299\u2013306","journal-title":"Biochim Biophys Acta"},{"key":"9513_CR30","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1126\/science.274.5288.784","volume":"274","author":"CY Wang","year":"1996","unstructured":"Wang CY, Mayo MW, Baldwin AS Jr (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274:784\u2013787","journal-title":"Science"},{"key":"9513_CR31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1476-4598-8-81","volume":"8","author":"S Wang","year":"2009","unstructured":"Wang S, Liu Q, Zhang Y, Liu K, Yu P, Liu K, Luan J, Duan H, Lu Z, Wang F, Wu E, Yagasaki K, Zhang G (2009) Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Mol Cancer 8:81","journal-title":"Mol Cancer"},{"key":"9513_CR32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/1471-2407-11-375","volume":"11","author":"S Wedel","year":"2011","unstructured":"Wedel S, Hudak L, Seibel JM, Makarevi\u0107 J, Juengel E, Tsaur I, Waaga-Gasser A, Haferkamp A, Blaheta RA (2011) Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis. BMC Cancer 11:375","journal-title":"BMC Cancer"},{"key":"9513_CR33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1368-7646(02)00120-6","volume":"5","author":"KA West","year":"2002","unstructured":"West KA, Castillo SS, Dennis PA (2002) Activation of the PI3K\/Akt pathway and chemotherapeutic resistance. Drug Resist Updat 5:234\u2013248","journal-title":"Drug Resist Updat"},{"key":"9513_CR34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10616-009-9225-9","volume":"59","author":"P Yu","year":"2009","unstructured":"Yu P, Liu Q, Liu K, Yagasaki K, Wu E, Zhang G (2009) Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology 59:219\u2013229","journal-title":"Cytotechnology"},{"key":"9513_CR35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1207\/S15327914NC382_16","volume":"38","author":"G Zhang","year":"2000","unstructured":"Zhang G, Miura Y, Yagasaki K (2000) Induction of apoptosis and cell cycle arrest in cancer cells by in vivo metabolites of teas. Nutr Cancer 38:265\u2013273","journal-title":"Nutr Cancer"},{"key":"9513_CR36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10616-009-9211-2","volume":"59","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Zhang H, Yu P, Liu Q, Liu K, Duan H, Luan G, Yagasaki K, Zhang G (2009) Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration. Cytotechnology 59:191\u2013200","journal-title":"Cytotechnology"},{"key":"9513_CR37","first-page":"614","volume":"66","author":"L Zhang","year":"2011","unstructured":"Zhang L, Wang G, Wang L, Song C, Wang X, Kang J (2011) Valproic acid inhibits prostate cancer cell migration by up-regulating E-cadherin expression. Pharmazie 66:614\u2013618","journal-title":"Pharmazie"},{"key":"9513_CR38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/156652412798889063","volume":"12","author":"G Zhang","year":"2012","unstructured":"Zhang G, Wang Y, Zhang Y, Wan X, Li J, Liu K, Wang F, Liu Q, Yang C, Yu P, Huang Y, Wang S, Jiang P, Qu Z, Luan J, Duan H, Zhang L, Hou A, Jin S, Hsieh TC, Wu E (2012a) Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy. Curr Mol Med 12:163\u2013176","journal-title":"Curr Mol Med"},{"key":"9513_CR39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11010-011-1085-x","volume":"361","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang G, Wang L, Song C, Leng Y, Wang X, Kang J (2012b) VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin. Mol Cell Biochem 361:39\u201345","journal-title":"Mol Cell Biochem"}],"container-title":["Cytotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10616-012-9513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10616-012-9513-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10616-012-9513-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:29:25Z","timestamp":1559230165000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10616-012-9513-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,16]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["9513"],"URL":"https:\/\/doi.org\/10.1007\/s10616-012-9513-7","relation":{},"ISSN":["0920-9069","1573-0778"],"issn-type":[{"value":"0920-9069","type":"print"},{"value":"1573-0778","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,16]]}}}